True Wealth Design’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.1K Sell
56
-8
-13% -$3.84K 0.01% 695
2026
Q1
$31.5K Buy
64
+21
+49% +$11.4K 0.01% 541
2025
Q4
$24.6K Buy
43
+1
+2% +$566 0.01% 538
2025
Q3
$20.4K Buy
42
+30
+250% +$14K 0.01% 606
2025
Q2
$5.04K Sell
12
-57
-83% -$23.8K ﹤0.01% 801
2025
Q1
$34.6K Buy
69
+57
+475% +$30.9K 0.01% 254
2024
Q4
$6.47K Sell
12
-16
-57% -$8.8K ﹤0.01% 489
2024
Q3
$17.3K Sell
28
-32
-53% -$18.9K 0.01% 342
2024
Q2
$33.2K Buy
60
+2
+3% +$1.15K 0.01% 187
2024
Q1
$33.7K Buy
58
+3
+5% +$1.68K 0.01% 182
2023
Q4
$29.2K Buy
55
+51
+1,275% +$24.7K 0.01% 184
2023
Q3
$2.02K Hold
4
﹤0.01% 265
2023
Q2
$2.09K Sell
4
-3
-43% -$1.62K ﹤0.01% 274
2023
Q1
$4.04K Buy
7
+3
+75% +$1.69K ﹤0.01% 284
2022
Q4
$2.2K Buy
+4
New +$2.12K ﹤0.01% 292

Other funds holding TMO

True Wealth Design's TMO Position: Q2 2026 in Review

True Wealth Design reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, selling an estimated $3.84K and leaving 56 shares worth $28.1K. The position accounts for 0.01% of the portfolio, ranked #695.

True Wealth Design first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $34.6K in Q1 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • True Wealth Design held 56 shares of Thermo Fisher Scientific worth $28.1K as of Q2 2026.
  • True Wealth Design sold 8 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.84K.
  • Thermo Fisher Scientific made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #695 holding.
  • True Wealth Design first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • True Wealth Design's Thermo Fisher Scientific position peaked at $34.6K in Q1 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.